Literature DB >> 18568398

Comments on: Yin W, Di G, Zhou L, Lu J, Liu G, Wu J, Shen K, Han Q, Shen Z, Shao Z. Time-varying pattern of recurrence risk for Chinese breast cancer patients.

James J Dignam, Vanja M Dukic.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18568398     DOI： 10.1007/s10549-008-0092-4

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN： 0167-6806            Impact factor:   4.872


× No keyword cloud information.
  3 in total

1.  Hazard of recurrence and adjuvant treatment effects over time in lymph node-negative breast cancer.

Authors:  James J Dignam; Vanja Dukic; Stewart J Anderson; Eleftherios P Mamounas; D Lawrence Wickerham; Norman Wolmark
Journal:  Breast Cancer Res Treat       Date:  2008-10-02       Impact factor: 4.872

2.  Trastuzumab Provides a Comparable Prognosis in Patients With HER2-Positive Breast Cancer to Those With HER2-Negative Breast Cancer: Post Hoc Analyses of a Randomized Controlled Trial of Post-Mastectomy Hypofractionated Radiotherapy.

Authors:  Guang-Yi Sun; Hao Jing; Shu-Lian Wang; Yong-Wen Song; Jing Jin; Hui Fang; Yue-Ping Liu; Hua Ren; Yu Tang; Xu-Ran Zhao; Yu-Chun Song; Si-Ye Chen; Zhuan-Bo Yang; Bo Chen; Yuan Tang; Ning Li; Ning-Ning Lu; Shu-Nan Qi; Yong Yang; Ye-Xiong Li
Journal:  Front Oncol       Date:  2021-01-26       Impact factor: 6.244

3.  Pattern of recurrence of early breast cancer is different according to intrinsic subtype and proliferation index.

Authors:  Nuria Ribelles; Lidia Perez-Villa; Jose Manuel Jerez; Bella Pajares; Luis Vicioso; Begoña Jimenez; Vanessa de Luque; Leonardo Franco; Elena Gallego; Antonia Marquez; Martina Alvarez; Alfonso Sanchez-Muñoz; Luis Perez-Rivas; Emilio Alba
Journal:  Breast Cancer Res       Date:  2013       Impact factor: 6.466
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.